North American Coral Snake Antivenin (Equine)

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 22, 2022
Approval ID: 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use North American Coral Snake Antivenin (Equine) safely and effectively. See full prescribing information for North American Coral Snake Antivenin (Equine). North American Coral Snake Antivenin (Equine)Lyophilized Powder for Solution for Intravenous InjectionInitial U.S. Approval: 1967

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.